Boehringer Ingelheim strengthens early science portfolio through comprehensive multifaceted partnership with Peking University
Research teams at PKU will work closely with their counterparts at Boehringer Ingelheim to leverage the company』s expertise in pharmaceutical research and development with their novel approaches an......
